Medical Weight Loss for Las Vegas, Nevada Residents
Las Vegas, Nevada residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Las Vegas through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Las Vegas Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Las Vegas, Nevada residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Las Vegas is served through telehealth from our Costa Mesa, California clinic, a neighboring-state metro where the full program runs by secure video, with medication shipped to your door.
Patients across Las Vegas and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Nevada. We care for patients throughout Downtown, Summerlin, Henderson nearby, the southwest, and the greater Las Vegas Valley. There is no distance surcharge for Las Vegas patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Our telehealth model serves Las Vegas and communities across Nevada with the same flat pricing and the same supervising physician. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Las Vegas patients.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Las Vegas patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Las Vegas
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Las Vegas address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Las Vegas
How do I get treatment from Las Vegas?
As a Las Vegas, Nevada patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Las Vegas?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Las Vegas in cold-pack packaging, no lines and no drive.
How much does it cost for Las Vegas patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Las Vegas do you serve?
We serve patients from across Las Vegas by telehealth, including Downtown, Summerlin, Henderson nearby, the southwest, and the greater Las Vegas Valley.
Is bilingual care available for Las Vegas patients?
Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations for Las Vegas patients, with Dr. Sharma supervising every case. The full telehealth program is available in Spanish.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Las Vegas, Nevada by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.